Table of Contents Author Guidelines Submit a Manuscript
Journal of Diabetes Research
Volume 2017 (2017), Article ID 1467213, 11 pages
https://doi.org/10.1155/2017/1467213
Research Article

A Comparison of Screening Tools for the Early Detection of Peripheral Neuropathy in Adults with and without Type 2 Diabetes

1Elizabeth City State University, Elizabeth City, NC, USA
2Old Dominion University, Norfolk, VA, USA
3Eastern Virginia Medical School, Norfolk, VA, USA

Correspondence should be addressed to Jennifer J. Brown; ude.udo@621worbj

Received 16 May 2017; Revised 31 July 2017; Accepted 13 September 2017; Published 8 November 2017

Academic Editor: Konstantinos Papatheodorou

Copyright © 2017 Jennifer J. Brown et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. I. Veresiu, C. I. Bondor, B. Florea, E. J. Vinik, A. I. Vinik, and N. A. Gâvan, “Detection of undisclosed neuropathy and assessment of its impact on quality of life: a survey in 25,000 Romanian patients with diabetes,” Journal of Diabetes and its Complications, vol. 29, pp. 644–649, 2015. View at Publisher · View at Google Scholar · View at Scopus
  2. A. I. Vinik, M.-L. Nevoret, C. Casellini, and H. Parson, “Diabetic neuropathy,” Endocrinology and Metabolism Clinics of North America, vol. 42, no. 4, pp. 747–787, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. A. V. Schwartz, E. Vittinghoff, D. E. Sellmeyer et al., “Diabetes-related complications, glycemic control, and falls in older adults,” Diabetes Care, vol. 31, no. 3, pp. 391–396, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. A. I. Vinik, E. J. Vinik, S. R. Colberg, and S. Morrison, “Falls risk in older adults with type 2 diabetes,” Clinics in Geriatric Medicine, vol. 31, pp. 89–99, 2015. View at Publisher · View at Google Scholar · View at Scopus
  5. J. Lamparter, P. Raum, N. Pfeiffer et al., “Prevalence and associations of diabetic retinopathy in a large cohort of prediabetic subjects: the Gutenberg Health Study,” Journal of Diabetes and its Complications, vol. 28, no. 4, pp. 482–487, 2014. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Dixit and A. Maiya, “Diabetic peripheral neuropathy and its evaluation in a clinical scenario: a review,” Journal of Postgraduate Medicine, vol. 60, no. 1, pp. 33–40, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. J. McKinlay, R. Piccolo, and L. Marceau, “An additional cause of health care disparities: the variable clinical decisions of primary care doctors,” Journal of Evaluation in Clinical Practice, vol. 19, no. 4, pp. 664–673, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. W. H. Herman and L. Kennedy, “Underdiagnosis of peripheral neuropathy in type 2 diabetes,” Diabetes Care, vol. 28, no. 6, pp. 1480-1481, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. M. L. Marcovecchio, M. Lucantoni, and F. Chiarelli, “Role of chronic and acute hyperglycemia in the development of diabetes complications,” Diabetes Technology & Therapeutics, vol. 13, no. 3, pp. 389–394, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. M. O. Goodarzi, “Type 2 Diabetes,” in Reference Module in Biomedical Sciences, Elsevier, 2014. View at Publisher · View at Google Scholar
  11. S. Y. Goh and M. E. Cooper, “The role of advanced glycation end products in progression and complications of diabetes,” The Journal of Clinical Endocrinology and Metabolism, vol. 93, no. 4, pp. 1143–1152, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. N. Papanas and D. Ziegler, “Prediabetic neuropathy: does it exist?” Current Diabetes Reports, vol. 12, no. 4, pp. 376–383, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. A. G. Tabák, C. Herder, W. Rathmann, E. J. Brunner, and M. Kivimäki, “Prediabetes: a high-risk state for diabetes development,” The Lancet, vol. 379, pp. 2279–2290, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. L. S. Phillips, R. E. Ratner, J. B. Buse, and S. E. Kahn, “We can change the natural history of type 2 diabetes,” Diabetes Care, vol. 37, no. 10, pp. 2668–2676, 2014. View at Publisher · View at Google Scholar · View at Scopus
  15. E. Mustafa, A. Alemam, and E. Hamid, “Subclinical peripheral neuropathy in prediabetics; correlation with glycosylated hemoglobin and C-reactive protein,” Egyptian Journal of Neurology, Psychiatry & Neurosurgery, vol. 49, 2012. View at Google Scholar
  16. G. A. Smith and R. J. Singleton, “Idiopathic neuropathy, prediabetes and the metabolic syndrome,” Journal of the Neurological Sciences, vol. 242, no. 1-2, pp. 9–14, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. G. A. Nichols, C. M. Alexander, C. J. Girman, S. J. Kamal-Bahl, and J. B. Brown, “Treatment escalation and rise in HbA1c following successful initial metformin therapy,” Diabetes Care, vol. 29, no. 3, pp. 504–509, 2006. View at Publisher · View at Google Scholar
  18. L. Monnier, M. Hanefeld, O. Schnell, C. Colette, and D. Owens, “Insulin and atherosclerosis: how are they related?” Diabetes & Metabolism, vol. 39, no. 2, pp. 111–117, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. J. A. Ruterbusch, “Prediabetes: the epidemic of the new milennium,” Nutritional Perspectives: Journal of the Council on Nutrition, vol. 37, no. 1, 2014. View at Google Scholar
  20. S. Baraz, K. Zarea, H. B. Shahbazian, and S. M. Latifi, “Comparison of the accuracy of monofilament testing at various points of feet in peripheral diabetic neuropathy screening,” Journal of Diabetes and Metabolic Disorders, vol. 13, no. 1, p. 19, 2014. View at Publisher · View at Google Scholar · View at Scopus
  21. M. E. Bourcier, J. Ullal, H. K. Parson et al., “Diabetic peripheral neuropathy: how reliable is a homemade 1-g monofilament for screening? A case-control study of sensitivity, specificity, and comparison with standardized sensory modalities,” Journal of Family Practice, vol. 55, no. 6, pp. 505–509, 2006. View at Google Scholar
  22. Y. Feng, F. J. Schlosser, and B. E. Sumpio, “The Semmes Weinstein monofilament examination as a screening tool for diabetic peripheral neuropathy,” Journal of Vascular Surgery, vol. 50, no. 3, pp. 675 e1–682 e1, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. J. Dros, A. Wewerinke, P. J. Bindels, and H. C. van Weert, “Accuracy of monofilament testing to diagnose peripheral neuropathy: a systematic review,” Annals of Family Medicine, vol. 7, no. 6, pp. 555–558, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. E. H. Tracey, A. J. Greene, and R. L. Doty, “Optimizing reliability and sensitivity of Semmes-Weinstein monofilaments for establishing point tactile thresholds,” Physiology & Behavior, vol. 105, no. 4, pp. 982–986, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. S. Divisova, E. Vlckova, M. Hnojcikova et al., “Prediabetes/early diabetes-associated neuropathy predominantly involves sensory small fibres,” Journal of the Peripheral Nervous System, vol. 17, pp. 341–350, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. C. C. Robinson, L. F. Balbinot, M. F. Silva, M. Achaval, and M. A. Zaro, “Plantar pressure distribution patterns of individuals with prediabetes in comparison with healthy individuals and individuals with diabetes,” Journal of Diabetes Science and Technology, vol. 7, no. 5, pp. 1113–1121, 2013. View at Publisher · View at Google Scholar · View at Scopus
  27. A. Boyd, C. Casselini, E. Vinik, and A. Vinik, “Quality of life and objective measures of diabetic neuropathy in a prospective placebo-controlled trial of ruboxistaurin and topiramate,” Journal of Diabetes Science and Technology, vol. 5, no. 3, pp. 714–722, 2011. View at Publisher · View at Google Scholar
  28. C. M. Casellini, P. M. Barlow, A. L. Rice et al., “A 6-month, randomized, double-masked, placebo-controlled study evaluating the effects of the protein kinase C-β inhibitor ruboxistaurin on skin microvascular blood flow and other measures of diabetic peripheral neuropathy,” Diabetes Care, vol. 30, pp. 896–902, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. E. J. Vinik, A. I. Vinik, J. F. Paulson et al., “Norfolk QOL-DN: validation of a patient reported outcome measure in transthyretin familial amyloid polyneuropathy,” Journal of the Peripheral Nervous System, vol. 19, no. 2, pp. 104–114, 2014. View at Publisher · View at Google Scholar · View at Scopus
  30. J. A. Lee, E. M. Halpern, L. E. Lovblom, E. Yeung, V. Bril, and B. A. Perkins, “Reliability and validity of a point-of-care sural nerve conduction device for identification of diabetic neuropathy,” PLoS One, vol. 9, no. 1, article e86515, 2014. View at Publisher · View at Google Scholar · View at Scopus
  31. B. A. Perkins, J. Grewal, E. Ng, M. Ngo, and V. Bril, “Validation of a novel point-of-care nerve conduction device for the detection of diabetic sensorimotor polyneuropathy,” Diabetes Care, vol. 29, no. 9, pp. 2023–2027, 2006. View at Publisher · View at Google Scholar · View at Scopus
  32. A. E. Moncrieft, “Inactivity, inflammation, and insulin resistance in type 2 diabetes and the metabolic syndrome, [M.S. thesis],” 2011, Retrieved from Miami University Libararies Scholarly Repository. View at Google Scholar
  33. E. Lenters-Westra and R. J. Slingerland, “Six of eight hemoglobin A1c point-of-care instruments do not meet the general accepted analytical performance criteria,” Clinical Chemistry, vol. 56, no. 1, pp. 44–52, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. M. Mannarino, M. Tonelli, and G. M. Allan, “Tools for practice: screening and diagnosis of type 2 diabetes with HbA1c,” Canadian Family Physician, vol. 59, no. 1, p. 42, 2013. View at Google Scholar
  35. E. Selvin, M. W. Steffes, E. Gregg, F. L. Brancati, and J. Coresh, “Performance of A1C for the classification and prediction of diabetes,” Diabetes Care, vol. 34, no. 1, pp. 84–89, 2011. View at Publisher · View at Google Scholar · View at Scopus
  36. B. A. Perkins, A. Orszag, J. Grewal, E. Ng, M. Ngo, and V. Bril, “Multi-site testing with a point-of-care nerve conduction device can be used in an algorithm to diagnose diabetic sensorimotor polyneuropathy,” Diabetes Care, vol. 31, no. 3, pp. 522–524, 2008. View at Publisher · View at Google Scholar · View at Scopus
  37. G. Pambianco, T. Costacou, E. Strotmeyer, and T. J. Orchard, “The assessment of clinical distal symmetric polyneuropathy in type 1 diabetes: a comparison of methodologies from the Pittsburgh Epidemiology of Diabetes Complications Cohort,” Diabetes Research and Clinical Practice, vol. 92, pp. 280–287, 2011. View at Publisher · View at Google Scholar · View at Scopus
  38. S. Sharma, P. R. Vas, and G. Rayman, “Assessment of diabetic neuropathy using a point-of-care nerve conduction device shows significant associations with the LDIFLARE method and clinical neuropathy scoring,” Journal of Diabetes Science and Technology, vol. 9, no. 1, pp. 123–131, 2015. View at Publisher · View at Google Scholar · View at Scopus
  39. A. I. Vinik, D. Y. Shapiro, C. Rauschkolb et al., “A randomized withdrawal, placebo-controlled study evaluating the efficacy and tolerability of tapentadol extended release in patients with chronic painful diabetic peripheral neuropathy,” Diabetes Care, vol. 37, no. 8, pp. 2302–2309, 2014. View at Publisher · View at Google Scholar · View at Scopus
  40. C. A. Abbott, A. L. Carrington, H. Ashe et al., “The North-West Diabetes Foot Care Study: incidence of, and risk factors for, new diabetic foot ulceration in a community-based patient cohort,” Diabetic Medicine, vol. 19, no. 5, pp. 377–384, 2002. View at Publisher · View at Google Scholar · View at Scopus
  41. J. B. Shin, Y. J. Seong, H. J. Lee, S. H. Kim, and J. R. Park, “Foot screening technique in a diabetic population,” Journal of Korean Medical Science, vol. 15, no. 1, pp. 78–82, 2000. View at Publisher · View at Google Scholar
  42. J. W. Meijer, A. J. Smit, J. D. Lefrandt, J. H. van der Hoeven, K. Hoogenberg, and T. P. Links, “Back to basics in diagnosing diabetic polyneuropathy with the tuning fork!,” Diabetes Care, vol. 28, no. 9, pp. 2201–2205, 2005. View at Publisher · View at Google Scholar · View at Scopus
  43. B. A. Perkins, D. Olaleye, B. Zinman, and V. Bril, “Simple screening tests for peripheral neuropathy in the diabetes clinic,” Diabetes Care, vol. 24, no. 2, pp. 250–256, 2001. View at Publisher · View at Google Scholar
  44. “Rapid screening for diabetic neuropathy,” Canadian Journal of Diabetes, vol. 37, pp. S197–S212, 2013.
  45. S. Bursova, J. Bednarik, E. Vlckova et al., “Prediabetes/early diabetes-associated polyneuropathy is predominantly preclinical and involves sensory small fibres,” Journal of Neurology, vol. 259, 2012. View at Google Scholar
  46. M. H. Haloua, I. Sierevelt, and W. J. Theuvenet, “Semmes-Weinstein monofilaments: influence of temperature, humidity, and age,” Journal of Hand Surgery, vol. 36, pp. 1191–1196, 2011. View at Publisher · View at Google Scholar · View at Scopus
  47. L. A. Lavery, D. E. Lavery, D. C. Lavery, J. Lafontaine, M. Bharara, and B. Najafi, “Accuracy and durability of Semmes-Weinstein monofilaments: what is the useful service life?” Diabetes Research and Clinical Practice, vol. 97, no. 3, pp. 399–404, 2012. View at Publisher · View at Google Scholar · View at Scopus
  48. N. Kafa, S. Citaker, Z. Tuna et al., “Is plantar foot sensation associated with standing balance in type 2 diabetes mellitus patients,” International Journal of Diabetes in Developing Countries, vol. 35, no. 3, pp. 405–410, 2015. View at Publisher · View at Google Scholar · View at Scopus
  49. S. Tesfaye, A. J. Boulton, P. J. Dyck et al., “Toronto Diabetic Neuropathy Expert Group. Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments,” Diabetes Care, vol. 33, no. 10, pp. 2285–2293, 2010. View at Publisher · View at Google Scholar · View at Scopus
  50. E. J. Vinik, R. P. Hayes, A. Oglesby et al., “The development and validation of the Norfolk QOL-DN, a new measure of patients’ perception of the effects of diabetes and diabetic neuropathy,” Diabetes Technology & Therapeutics, vol. 7, no. 3, pp. 497–508, 2005. View at Publisher · View at Google Scholar · View at Scopus
  51. E. J. Vinik, J. F. Paulson, S. L. Ford-Molvik, and A. I. Vinik, “German-translated Norfolk quality of life (QOL-DN) identifies the same factors as the English version of the tool and discriminates different levels of neuropathy severity,” Journal of Diabetes Science and Technology, vol. 2, no. 6, pp. 1075–1086, 2008. View at Publisher · View at Google Scholar
  52. F. Hogg, G. Peach, P. Price, M. Thompson, and R. Hinchliffe, “Measures of health-related quality of life in diabetes-related foot disease: a systematic review,” Diabetologia, vol. 55, no. 3, pp. 552–565, 2012. View at Publisher · View at Google Scholar · View at Scopus
  53. B. Taksande, S. Ansari, A. Jaikishan, and V. Karwasara, “The diagnostic sensitivity, specificity and reproducibility of the clinical physical examination signs in patients of diabetes mellitus for making diagnosis of peripheral neuropathy,” Journal of Endocrinology and Metabolism, vol. 1, no. 1, pp. 21–26, 2011. View at Google Scholar
  54. K. R. Ylitalo, M. Sowers, and S. Heeringa, “Peripheral vascular disease and peripheral neuropathy in individuals with cardiometabolic clustering and obesity: National Health and Nutrition Examination Survey 2001-2004,” Diabetes Care, vol. 34, no. 7, pp. 1642–1647, 2011. View at Publisher · View at Google Scholar · View at Scopus
  55. S. C. Smith, D. L. Lamping, and G. D. Maclaine, “Measuring health-related quality of life in diabetic peripheral neuropathy: a systematic review,” Diabetes Research and Clinical Practice, vol. 96, no. 3, pp. 261–270, 2012. View at Publisher · View at Google Scholar · View at Scopus
  56. A. G. Smith and J. R. Singleton, “Obesity and hyperlipidemia are risk factors for early diabetic neuropathy,” Journal of Diabetes and its Complications, vol. 27, no. 5, pp. 436–442, 2013. View at Publisher · View at Google Scholar · View at Scopus
  57. S. Farhan, R. Jarai, I. Tentzeris et al., “Comparison of HbA1c and oral glucose tolerance test for diagnosis of diabetes in patients with coronary artery disease,” Clinical Research in Cardiology, vol. 101, no. 8, pp. 625–630, 2012. View at Publisher · View at Google Scholar · View at Scopus
  58. J. Booth and M. J. Young, “Differences in the performance of commercially available 10-g monofilaments,” Diabetes Care, vol. 23, no. 7, pp. 984–988, 2000. View at Publisher · View at Google Scholar
  59. J. J. Brown, Neuropathy Detection, Quality of Life Tools & Treatment for Type 2 Diabetes, [Ph.D. thesis], Old Dominion University ODU Digital Commons, Norfolk, VA, USA, 2016, Human Movement Sciences Theses & Dissertations. Paper 2.